Building Project Success Through Translation

The BioMedTech Horizons Program is focused on supporting translation of Australian medical technology innovation to address key health challenges. MTPConnect convened our Round 1 BioMedTech Horizons Program recipients together in Melbourne for a chance to hear about all projects underway, swap ideas on challenges being faced and gain advice from commercialisation experts. Listen in to Carina Biotech’s Professor Jane Rathjen, Griffith University’s Professor David Lloyd and Professor Randy Bindra, and Garvan Institute of Medical Research’s Professor Luke Hesson. The episode also features MTPConnect Managing Director & CEO Dr Dan Grant and intellectual property expert Rob McInness, Principal at Rob McInness IP Advisory.Credits: Host Shannan Osrin.